The Human Papillomavirus Head and Neck Cancer Epidemic: What You Need to Know

Abstract

Program Description:

Human papillomavirus (HPV)–associated head and neck cancer is an epidemic striking a younger and healthier population without the usual risk factors for head and neck cancer. Most patients have an excellent prognosis following treatment with surgery or chemoradiation, and the sequela of long-term morbidity from treatment is of increasing concern as patients are expected to live long enough to experience complications. Failure to identify a subset of patients at high risk for metastasis, recurrence, and decreased survival can lead to undertreatment and poor outcomes. This miniseminar will discuss the epidemiology, workup, treatment, and surveillance of HPV-positive head and neck cancer.

Educational Objectives:

(1) Describe features of HPV-positive head and neck cancer. (2) Recognize the role of surgical and nonsurgical therapy in the treatment of HPV-positive head and neck cancer. (3) Explain the indications for adjuvant treatment in the management of HPV-positive head and neck cancer.